共 75 条
[1]
Altorki NK(2003)Celecoxib, a selective cyclooxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer J Clin Oncol 21 2645-2650
[2]
Keresztes RS(2004)The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin? Pharmacol Res 50 487-498
[3]
Port JL(2003)NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells Oncogene 22 90-97
[4]
Awara WM(2004)CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAATbox in human cancer cells Mol Pharmacol 65 906-916
[5]
El Sisi AE(2004)Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer Clin Cancer Res 10 2694-2704
[6]
El Sayad ME(2003)Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise Cancer Cell 4 431-436
[7]
Bentires Alj M(1999)Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells Breast Cancer Res Treat 53 229-240
[8]
Barbu V(2002)The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line Hepatology 35 843-852
[9]
Fillet M(2005)Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells Mol Cancer Ther 4 1358-1363
[10]
Chen GK(1997)AP-1 function and regulation Curr Opin Cell Biol 9 240-246